“Raised white cell count”的搜索结果，显示 361-370 项，共有 7895 项

1. 血液科- 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

2. 血液科- 临床试验- 妙佑医疗国际

   ... blood forming cells that were destroyed by the chemotherapy. Giving high dose chemotherapy followed by an autologous stem cell transplant may be more ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This is a peripheral blood Collection Protocol to study the T-cell ... high (80-90%) frequency of MUC1 ... count ≥ 1,500 /microliter, and platelets ...

4. 血红蛋白计数低病因- 妙佑医疗国际

   Anemia (low red blood cell counts). American Cancer Society. https://www.cancer.org/cancer/managing-cancer/side-effects/low-blood-counts/anemia.html ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... blood forming cells that were destroyed by the chemotherapy. Giving high dose chemotherapy followed by an autologous stem cell transplant may be more ...

6. 血液科- 临床试验- 妙佑医疗国际

   This is a peripheral blood Collection Protocol to study the T-cell ... high (80-90%) frequency of MUC1 ... count ≥ 1,500 /microliter, and platelets ...

7. 神经科- 临床试验- 妙佑医疗国际

   This is a peripheral blood Collection Protocol to study the T-cell ... high (80-90%) frequency of MUC1 ... count ≥ 1,500 /microliter, and platelets ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Olaparib and cediranib maleate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. ... increased risk of secondary non- ...

9. 血液科- 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

10. 胃肠病科和肝病科- 临床试验- 妙佑医疗国际

    Rochester, Minn. To understand the utility of measuring stomach emptying, symptoms during a stomach emptying, and blood markers of body metabolism. Comparison ...